David Wheadon

David Wheadon

Director/Board Member chez SOTERA HEALTH COMPANY

Fortune : 447 824 $ au 31/03/2024

66 ans
Health Technology
Commercial Services
Consumer Services

Profil

David E.
Wheadon
is currently the Director at PSKW LLC, Independent Director at Sotera Health Co., Lead Independent Director at Vaxart, Inc., and a Member of the American Psychiatric Association and the American Academy of Pharmaceutical Physicians.
Previously, he held positions as Director at Assertio Therapeutics, Inc., Independent Director at ChemoCentryx, Inc., Director-Clinical Research at Smithkline Beecham Pharmaceuticals Ltd., Director at Make-A-Wish Foundation of Illinois, Director at Assertio Holdings, Inc., Independent Director at Karuna Therapeutics, Inc., Senior VP-Global Pharmaceutical Regulatory at Abbott Laboratories, Clinical Research Physician at Eli Lilly & Co., Senior Vice President-Global Regulatory Affairs at AstraZeneca PLC, Senior Vice President-US Regulatory Affairs at GSK Plc, Senior Vice President-Global Regulatory Affairs & Patient Safety at AstraZeneca Pharmaceuticals LP, Executive Vice President-Research & Advocacy at JDRF International, Senior VP-Scientific & Regulatory Affairs at Pharmaceutical Research & Manufacturers of America, and Executive Vice President-Research & Advocacy at Juvenile Diabetes Research Foundation.
He received his undergraduate degree from Harvard University and his doctorate from The Johns Hopkins University School of Medicine.

Détentions connues dans des sociétés publiques

SociétéDateNombre d'actionsValorisationDate de valorisation
26/05/2023 35 691 ( 0,01% ) 428 649 $ 31/03/2024
26/06/2023 14 750 ( 0,01% ) 19 175 $ 31/03/2024

Postes actifs de David Wheadon

SociétésPosteDébut
VAXART, INC. Director/Board Member 21/04/2021
SOTERA HEALTH COMPANY Director/Board Member 01/05/2021
Director/Board Member 01/12/2020
Director/Board Member -
American Academy of Pharmaceutical Physicians Corporate Officer/Principal -
Tous les postes actifs de David Wheadon

Anciens postes connus de David Wheadon

SociétésPosteFin
KARA THER Director/Board Member 18/03/2024
CHEMOCENTRYX, INC. Director/Board Member 20/10/2022
ASSERTIO HOLDINGS, INC. Director/Board Member 30/12/2020
ASTRAZENECA PLC General Counsel 01/07/2019
░░░░░░░░░░░ ░░░░░░░░░░░░░░░ ░░ ░░░░░░░░░ ░░░░░░░░░░░░░░░░░ ░░░░░░░░░░
Voir l'expérience en détail de David Wheadon

Formation de David Wheadon

Harvard University Undergraduate Degree
The Johns Hopkins University School of Medicine Doctorate Degree

Expériences
Fonctions occupées

Actives

Inactives

Sociétés cotées

Entreprise privées

Voir l'expérience en détail de David Wheadon

Relations

100 +

Relations au 1er degré

21

Entreprises liées au 1er degré

Homme

Femme

Administrateurs

Exécutifs

Voir le réseau personnel

Sociétés liées

Sociétés cotées7
ABBOTT LABORATORIES

Health Technology

ELI LILLY AND COMPANY

Health Technology

ASTRAZENECA PLC

Health Technology

GSK PLC

Health Technology

SOTERA HEALTH COMPANY

Health Technology

VAXART, INC.

Health Technology

ASSERTIO HOLDINGS, INC.

Health Technology

Entreprise privées12

Health Technology

Health Technology

Commercial Services

Health Technology

Commercial Services

Health Technology

American Academy of Pharmaceutical Physicians

Smithkline Beecham Pharmaceuticals Ltd.

Commercial Services

Health Technology

Make-A-Wish Foundation of Illinois

Commercial Services

Voir les connexions sociétés
  1. Bourse
  2. Insiders
  3. David Wheadon